Factors Influencing Prescribing of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Primary Care

Prescribing rates of sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) remain suboptimal despite established cardiovascular and kidney benefits.

• Clinicians' knowledge about SGLT2i and GLP-1 RA may influence their prescribing behavior.
• Comfort with prescribing these medications is potentially linked to their familiarity with the drugs.
• Factors affecting the prescription of SGLT2i and GLP-1 RA include clinician education and perceived patient needs.

Simplified